Article metrics

other Versions

Download PDFPDF

Trials in progress: IMagyn050/GOG 3015/ENGOT-OV39. A Phase III, multicenter, randomized study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer

 

Online download statistics by month:

Online download statistics by month: January 2019 to March 2023

AbstractFullPdf
Jan 20195614423
Feb 20195193716
Mar 2019499209
Apr 201920979
May 2019239177
Jun 20198252
Jul 2019171129
Aug 201918979
Sep 20199255
Oct 201914666
Nov 20191631211
Dec 201922226
Jan 20201391314
Feb 2020228313
Mar 2020147106
Apr 2020206117
May 2020212814
Jun 20202461512
Jul 2020440710
Aug 202021391
Sep 202017384
Oct 202021242
Nov 202017464
Dec 2020182165
Jan 202118641
Feb 202110042
Mar 202114837
Apr 20211951111
May 20214712
Jun 2021821
Jul 20211452
Aug 2021514
Sep 20211282
Oct 20216862
Nov 202111892
Dec 202110275
Jan 202211691
Feb 20229942
Mar 202214543
Apr 202211564
May 202211762
Jun 202215373
Jul 20228631
Aug 202215242
Sep 202210451
Oct 202212213
Nov 202212110
Dec 202212601
Jan 20239232
Feb 202310210
Mar 202310350
Total8420404270